Transition metal-catalysed bioorthogonal reactions are severely hindered in biomedical applications, mainly due to a lack of target specificity. Now, research shows that a trojan exosome vesicle can deliver a palladium catalyst specifically to progenitor cells for bioorthogonal catalysis, allowing localized prodrug activation.
Access options
Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.

References
- 1.
Sletten, E. M. & Bertozzi, C. R. Angew. Chem. Int. Ed. 48, 6974–6998 (2009).
- 2.
Soldevila-Barreda, J. J. & Metzler-Nolte, N. Chem. Rev. 119, 829–869 (2019).
- 3.
Ji, X. et al. Chem. Soc. Rev. 48, 1077–1094 (2019).
- 4.
Wang, F., Zhang, Y., Du, Z., Ren, J. & Qu, X. Nat. Commun. 9, 1209 (2018).
- 5.
Sancho-Albero, M. et al. Nat. Catal. https://doi.org/10.1038/s41929-019-0333-4 (2019).
- 6.
Alvarez-Erviti, L. et al. Nat. Biotechnol. 29, 341–345 (2011).
- 7.
Dong, H. et al. Anal. Chem. 90, 4507–4513 (2018).
- 8.
Ngo, A. H., Bose, S. & Do, L. H. Chem. Eur. J. 24, 10584–10594 (2018).
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Du, Z., Qu, X. Exosomes for cell-targeted bioorthogonal catalysis. Nat Catal 2, 837–838 (2019). https://doi.org/10.1038/s41929-019-0350-3
Published:
Issue Date:
Further reading
-
Catalytically potent and selective clusterzymes for modulation of neuroinflammation through single-atom substitutions
Nature Communications (2021)
-
Membrane vesicles nanotheranostic systems: sources, engineering methods, and challenges
Biomedical Materials (2021)
-
Transition Metal‐Promoted Reactions in Aqueous Media and Biological Settings
Chemistry – A European Journal (2021)
-
Design and Engineering of Metal Catalysts for Bio-orthogonal Catalysis in Living Systems
ACS Applied Bio Materials (2020)